Skip to content

Urgent urology symptoms What to do

PSA test for prostate cancer not recommended: panel

Urology TodayPublished October 10, 20115 min read

Key points

  • Doctors criticized proposals by a government-backed panel recommending against prostate cancer screening in healthy men—saying they went too far and may put some men at risk of the deadly cancer.
  • The task force made its recommendation based on a review of scientific evidence that suggested the benefits of fewer cancer deaths was overshadowed by potential serious side effects from treating a cancer that might never have caused any harm.
  • “Prostate cancer remains the second-leading cause of cancer death in the United States,” Dr.
  • Several European clinical trials have also shown PSA screening saves lives, Eggener said.

Doctors criticized proposals by a government-backed panel recommending against prostate cancer screening in healthy men—saying they went too far and may put some men at risk of the deadly cancer.

The U.S. Preventive Services Task Force, which advises the government on health prevention measures, on Friday downgraded its recommendation on prostate cancer screening to a “D,” which means it recommends against the service because “there is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits.”

It had previously said there was not enough evidence to make a call on the use of prostate-specific antigen, or PSA, tests that measure levels in the blood of a protein.

The task force made its recommendation based on a review of scientific evidence that suggested the benefits of fewer cancer deaths was overshadowed by potential serious side effects from treating a cancer that might never have caused any harm.

The same panel caused a media storm in 2009 after it recommended doctors scale back on routine mammograms for women in their 40s and 50s.

“Prostate cancer remains the second-leading cause of cancer death in the United States,” Dr. Scott Eggener, a surgeon who specializes in prostate cancer at the University of Chicago.

He said while not perfect, PSA screening has definitely saved lives, noting that widespread PSA screening in the United States has resulted in a 30 percent decrease in death rates when adjusted for men’s ages.

Several European clinical trials have also shown PSA screening saves lives, Eggener said.

“Put simply, when PSA screening is used, fewer men develop metastatic prostate cancer or die from it,” he said.

SEVERAL CAUSES OF HIGH PSA

High or increasing levels of PSA can indicate an increased risk for prostate cancer, but elevated PSA levels can be caused by other things too, such as infections, an enlarged prostate or even recent ejaculation.

Studies have shown that widespread use of PSA tests has resulted in high rates of false positives and overtreatment for cancers that might never have caused harm.

And the treatments—usually surgery and radiation—are not benign. They often result in impotence and incontinence.

Simply being diagnosed with prostate cancer can cause anxiety and harm. A study by researchers at Harvard and Brigham & Women’s Hospital in Boston last year found that being diagnosed with prostate cancer roughly doubles the risk of suicide or death from a heart attack.

Results of studies looking at the benefits of widespread prostate cancer screening have been mixed, according to the conclusions of a review of studies set to be published next week but released early by the Annals of Internal Medicine.

That review, which is used by the task force to make its recommendations, noted that of the five screening trials it studied, the two largest and highest-quality studies reported conflicting results. One found screening was associated with reduced prostate cancer deaths compared with no screening in men age 55 to 69 after nine years.

The other found no statistically significant benefit after 10 years. And of the men who had three or four rounds of screening, the false positive rate was 12 to 13 percent.

“Prostate-specific antigen-based screening results in small or no reduction in prostate cancer-specific mortality and is associated with harms related to subsequent evaluation and treatments, some of which may be unnecessary,” the report concluded.

TOO DRASTIC

Critics said the studies were too short and argued that there is evidence that PSA screening saves lives.

“I think they are a little premature,” said Dr. Andrew Lee, a radiation oncologist at University of Texas MD Anderson Cancer Center.

Lee said moving from saying there is not enough information to saying a test is recommended is too drastic given that the evidence is so inconclusive.

“I know some of the studies did look bad,” Lee said. “In my personal review of the literature, there are arguments both ways. If that is the case, as a physician I would err on the side of being more conservative.

“I don’t think the data is at all conclusive to make such a strong recommendation as a ‘D’ rating,” he said.

Dr. Herbert Lepor, a urology professor at New York University School of Medicine, said the claim that screening studies fail to show a benefit is inaccurate, pointing to a Scandinavian study with 14 years years of follow up that showed screening cut prostate cancer deaths by 50 percent.

“The U.S. Preventive Services Task Force is a group of primary care physicians like pediatricians and OB/GYNs who never treat prostate cancer. They have simply misinterpreted the studies and have not seen men die of this fatal disease,” Lepor said.

The proposed guidelines are meant to discourage PSA testing in healthy men; they do not apply to men suspected of having prostate cancer.

They had been scheduled to be released in the Annals of Internal Medicine on Monday, but leaks of the recommendations to news outlets forced the group to post the guidelines early. It was first reported by CNN on Thursday.

The recommendations will be available for a 30-day comment period before final treatment guidelines are released.

According to the American Cancer Society, about 1 man in 6 will be diagnosed with prostate cancer in his lifetime. More than 2 million U.S. men who have been diagnosed with prostate cancer at some point are still alive today.

###

By Julie Steenhuysen

CHICAGO

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. If you cannot pass urine, have a fever with back or side pain, or sudden severe pain in the testicle, call 911 or go to an emergency department.

Urinary symptoms?

Weak stream, urgency, up at night? Score it in two minutes.

Seven questions from the International Prostate Symptom Score show whether symptoms are mild, moderate or severe, and when to see a doctor.

Take the symptom score

When to get help

Most urology problems can wait for an appointment. These can’t.

Call 911 or go to an emergency department if you have any of these:

  • You cannot pass urine at allAcute urinary retention: a painful, swollen bladder. It needs a catheter, often within hours.
  • Fever or chills with back or side painA blocked, infected kidney (for example behind a stone) can turn into sepsis quickly.
  • Sudden, severe pain in a testiclePossible testicular torsion. The testicle can often be saved only within about 6 hours.
  • An erection lasting over 4 hoursPriapism. Without treatment it can cause permanent damage.
Call 911

Outside the US, call your local emergency number.

See a doctor within days

  1. 01Blood in your urineEven once, and even without pain. Usually harmless, but it is the most common first sign of bladder and kidney cancer.
  2. 02Burning, frequent or cloudy urineTypical of a urinary tract infection, which usually clears with treatment.
  3. 03A lump or swelling in a testicleMost lumps are benign; testicular cancer is very treatable when found early.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.